XOMA 358, a Novel Treatment for Hyperinsulinemic Hypoglycemia: Safety[...]
Continuous Glucose Monitoring (CGM) Reveals Undertreated Hypoglycemia[...]
Phase 2b RIZE Data Presentation by Hüseyin Demirbilek, M.D. at ESPE 2022
29/05/2020 | Press release | Archived content
Please select the service you want to use:
Smartlinks | Rezolute Inc. | News | Health | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Pharmaceuticals | Securities Issuers | Biotechnology and Medical Research Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact